Our portfolio companies

Portfolio Our portfolio companies

Pulmagen Therapeutics

Pulmagen Therapeutics

Developing oral and inhaled medicines for chronic lung disease.

Pulmagen’s clinical and preclinical pipeline of therapies for chronic respiratory diseases such as COPD, asthma and cystic fibrosis delivers both symptomatic relief (bronchodilators) and a disease modifying effect (anti-inflammatory).

  • Industry Biotech